Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Pet Vaccine Market Growth 2022-2028

  • LP 4736900
  • 104 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Pet Vaccine will have significant change from previous year. According to our (LP Information) latest study, the global Pet Vaccine market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Pet Vaccine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Pet Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Pet Vaccine market, reaching US$ million by the year 2028. As for the Europe Pet Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Pet Vaccine players cover Bayer Healthcare, Vetoquinol S.A, Boehringer Ingelheim, and Ceva, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Pet Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Attenuated Live Vaccines

Conjugate Vaccines

Inactivated Vaccines

Subunit Vaccines

Toxoid Vaccines

DNA Vaccines

Recombinant Vaccines

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Canine

Avian

Feline

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Bayer Healthcare

Vetoquinol S.A

Boehringer Ingelheim

Ceva

Eli Lilly

Heska Co.

Merck Animal Health

Merial (Sanofi)

Virbac

Zoetis (Pfizer)

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Pet Vaccine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Pet Vaccine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Pet Vaccine by Country/Region, 2017, 2022 & 2028

2.2 Pet Vaccine Segment by Type

2.2.1 Attenuated Live Vaccines

2.2.2 Conjugate Vaccines

2.2.3 Inactivated Vaccines

2.2.4 Subunit Vaccines

2.2.5 Toxoid Vaccines

2.2.6 DNA Vaccines

2.2.7 Recombinant Vaccines

2.3 Pet Vaccine Sales by Type

2.3.1 Global Pet Vaccine Sales Market Share by Type (2017-2022)

2.3.2 Global Pet Vaccine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Pet Vaccine Sale Price by Type (2017-2022)

2.4 Pet Vaccine Segment by Application

2.4.1 Canine

2.4.2 Avian

2.4.3 Feline

2.5 Pet Vaccine Sales by Application

2.5.1 Global Pet Vaccine Sale Market Share by Application (2017-2022)

2.5.2 Global Pet Vaccine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Pet Vaccine Sale Price by Application (2017-2022)

3 Global Pet Vaccine by Company

3.1 Global Pet Vaccine Breakdown Data by Company

3.1.1 Global Pet Vaccine Annual Sales by Company (2020-2022)

3.1.2 Global Pet Vaccine Sales Market Share by Company (2020-2022)

3.2 Global Pet Vaccine Annual Revenue by Company (2020-2022)

3.2.1 Global Pet Vaccine Revenue by Company (2020-2022)

3.2.2 Global Pet Vaccine Revenue Market Share by Company (2020-2022)

3.3 Global Pet Vaccine Sale Price by Company

3.4 Key Manufacturers Pet Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Pet Vaccine Product Location Distribution

3.4.2 Players Pet Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Pet Vaccine by Geographic Region

4.1 World Historic Pet Vaccine Market Size by Geographic Region (2017-2022)

4.1.1 Global Pet Vaccine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Pet Vaccine Annual Revenue by Geographic Region

4.2 World Historic Pet Vaccine Market Size by Country/Region (2017-2022)

4.2.1 Global Pet Vaccine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Pet Vaccine Annual Revenue by Country/Region

4.3 Americas Pet Vaccine Sales Growth

4.4 APAC Pet Vaccine Sales Growth

4.5 Europe Pet Vaccine Sales Growth

4.6 Middle East & Africa Pet Vaccine Sales Growth

5 Americas

5.1 Americas Pet Vaccine Sales by Country

5.1.1 Americas Pet Vaccine Sales by Country (2017-2022)

5.1.2 Americas Pet Vaccine Revenue by Country (2017-2022)

5.2 Americas Pet Vaccine Sales by Type

5.3 Americas Pet Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Pet Vaccine Sales by Region

6.1.1 APAC Pet Vaccine Sales by Region (2017-2022)

6.1.2 APAC Pet Vaccine Revenue by Region (2017-2022)

6.2 APAC Pet Vaccine Sales by Type

6.3 APAC Pet Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Pet Vaccine by Country

7.1.1 Europe Pet Vaccine Sales by Country (2017-2022)

7.1.2 Europe Pet Vaccine Revenue by Country (2017-2022)

7.2 Europe Pet Vaccine Sales by Type

7.3 Europe Pet Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Pet Vaccine by Country

8.1.1 Middle East & Africa Pet Vaccine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Pet Vaccine Revenue by Country (2017-2022)

8.2 Middle East & Africa Pet Vaccine Sales by Type

8.3 Middle East & Africa Pet Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Pet Vaccine

10.3 Manufacturing Process Analysis of Pet Vaccine

10.4 Industry Chain Structure of Pet Vaccine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Pet Vaccine Distributors

11.3 Pet Vaccine Customer

12 World Forecast Review for Pet Vaccine by Geographic Region

12.1 Global Pet Vaccine Market Size Forecast by Region

12.1.1 Global Pet Vaccine Forecast by Region (2023-2028)

12.1.2 Global Pet Vaccine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Pet Vaccine Forecast by Type

12.7 Global Pet Vaccine Forecast by Application

13 Key Players Analysis

13.1 Bayer Healthcare

13.1.1 Bayer Healthcare Company Information

13.1.2 Bayer Healthcare Pet Vaccine Product Offered

13.1.3 Bayer Healthcare Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Bayer Healthcare Main Business Overview

13.1.5 Bayer Healthcare Latest Developments

13.2 Vetoquinol S.A

13.2.1 Vetoquinol S.A Company Information

13.2.2 Vetoquinol S.A Pet Vaccine Product Offered

13.2.3 Vetoquinol S.A Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Vetoquinol S.A Main Business Overview

13.2.5 Vetoquinol S.A Latest Developments

13.3 Boehringer Ingelheim

13.3.1 Boehringer Ingelheim Company Information

13.3.2 Boehringer Ingelheim Pet Vaccine Product Offered

13.3.3 Boehringer Ingelheim Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Boehringer Ingelheim Main Business Overview

13.3.5 Boehringer Ingelheim Latest Developments

13.4 Ceva

13.4.1 Ceva Company Information

13.4.2 Ceva Pet Vaccine Product Offered

13.4.3 Ceva Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Ceva Main Business Overview

13.4.5 Ceva Latest Developments

13.5 Eli Lilly

13.5.1 Eli Lilly Company Information

13.5.2 Eli Lilly Pet Vaccine Product Offered

13.5.3 Eli Lilly Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Eli Lilly Main Business Overview

13.5.5 Eli Lilly Latest Developments

13.6 Heska Co.

13.6.1 Heska Co. Company Information

13.6.2 Heska Co. Pet Vaccine Product Offered

13.6.3 Heska Co. Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Heska Co. Main Business Overview

13.6.5 Heska Co. Latest Developments

13.7 Merck Animal Health

13.7.1 Merck Animal Health Company Information

13.7.2 Merck Animal Health Pet Vaccine Product Offered

13.7.3 Merck Animal Health Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Merck Animal Health Main Business Overview

13.7.5 Merck Animal Health Latest Developments

13.8 Merial (Sanofi)

13.8.1 Merial (Sanofi) Company Information

13.8.2 Merial (Sanofi) Pet Vaccine Product Offered

13.8.3 Merial (Sanofi) Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Merial (Sanofi) Main Business Overview

13.8.5 Merial (Sanofi) Latest Developments

13.9 Virbac

13.9.1 Virbac Company Information

13.9.2 Virbac Pet Vaccine Product Offered

13.9.3 Virbac Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Virbac Main Business Overview

13.9.5 Virbac Latest Developments

13.10 Zoetis (Pfizer)

13.10.1 Zoetis (Pfizer) Company Information

13.10.2 Zoetis (Pfizer) Pet Vaccine Product Offered

13.10.3 Zoetis (Pfizer) Pet Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Zoetis (Pfizer) Main Business Overview

13.10.5 Zoetis (Pfizer) Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Pet Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Pet Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Attenuated Live Vaccines

Table 4. Major Players of Conjugate Vaccines

Table 5. Major Players of Inactivated Vaccines

Table 6. Major Players of Subunit Vaccines

Table 7. Major Players of Toxoid Vaccines

Table 8. Major Players of DNA Vaccines

Table 9. Major Players of Recombinant Vaccines

Table 10. Global Pet Vaccine Sales by Type (2017-2022) & (K Doses)

Table 11. Global Pet Vaccine Sales Market Share by Type (2017-2022)

Table 12. Global Pet Vaccine Revenue by Type (2017-2022) & ($ million)

Table 13. Global Pet Vaccine Revenue Market Share by Type (2017-2022)

Table 14. Global Pet Vaccine Sale Price by Type (2017-2022) & (USD/Dose)

Table 15. Global Pet Vaccine Sales by Application (2017-2022) & (K Doses)

Table 16. Global Pet Vaccine Sales Market Share by Application (2017-2022)

Table 17. Global Pet Vaccine Revenue by Application (2017-2022)

Table 18. Global Pet Vaccine Revenue Market Share by Application (2017-2022)

Table 19. Global Pet Vaccine Sale Price by Application (2017-2022) & (USD/Dose)

Table 20. Global Pet Vaccine Sales by Company (2020-2022) & (K Doses)

Table 21. Global Pet Vaccine Sales Market Share by Company (2020-2022)

Table 22. Global Pet Vaccine Revenue by Company (2020-2022) ($ Millions)

Table 23. Global Pet Vaccine Revenue Market Share by Company (2020-2022)

Table 24. Global Pet Vaccine Sale Price by Company (2020-2022) & (USD/Dose)

Table 25. Key Manufacturers Pet Vaccine Producing Area Distribution and Sales Area

Table 26. Players Pet Vaccine Products Offered

Table 27. Pet Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 28. New Products and Potential Entrants

Table 29. Mergers & Acquisitions, Expansion

Table 30. Global Pet Vaccine Sales by Geographic Region (2017-2022) & (K Doses)

Table 31. Global Pet Vaccine Sales Market Share Geographic Region (2017-2022)

Table 32. Global Pet Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 33. Global Pet Vaccine Revenue Market Share by Geographic Region (2017-2022)

Table 34. Global Pet Vaccine Sales by Country/Region (2017-2022) & (K Doses)

Table 35. Global Pet Vaccine Sales Market Share by Country/Region (2017-2022)

Table 36. Global Pet Vaccine Revenue by Country/Region (2017-2022) & ($ millions)

Table 37. Global Pet Vaccine Revenue Market Share by Country/Region (2017-2022)

Table 38. Americas Pet Vaccine Sales by Country (2017-2022) & (K Doses)

Table 39. Americas Pet Vaccine Sales Market Share by Country (2017-2022)

Table 40. Americas Pet Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 41. Americas Pet Vaccine Revenue Market Share by Country (2017-2022)

Table 42. Americas Pet Vaccine Sales by Type (2017-2022) & (K Doses)

Table 43. Americas Pet Vaccine Sales Market Share by Type (2017-2022)

Table 44. Americas Pet Vaccine Sales by Application (2017-2022) & (K Doses)

Table 45. Americas Pet Vaccine Sales Market Share by Application (2017-2022)

Table 46. APAC Pet Vaccine Sales by Region (2017-2022) & (K Doses)

Table 47. APAC Pet Vaccine Sales Market Share by Region (2017-2022)

Table 48. APAC Pet Vaccine Revenue by Region (2017-2022) & ($ Millions)

Table 49. APAC Pet Vaccine Revenue Market Share by Region (2017-2022)

Table 50. APAC Pet Vaccine Sales by Type (2017-2022) & (K Doses)

Table 51. APAC Pet Vaccine Sales Market Share by Type (2017-2022)

Table 52. APAC Pet Vaccine Sales by Application (2017-2022) & (K Doses)

Table 53. APAC Pet Vaccine Sales Market Share by Application (2017-2022)

Table 54. Europe Pet Vaccine Sales by Country (2017-2022) & (K Doses)

Table 55. Europe Pet Vaccine Sales Market Share by Country (2017-2022)

Table 56. Europe Pet Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 57. Europe Pet Vaccine Revenue Market Share by Country (2017-2022)

Table 58. Europe Pet Vaccine Sales by Type (2017-2022) & (K Doses)

Table 59. Europe Pet Vaccine Sales Market Share by Type (2017-2022)

Table 60. Europe Pet Vaccine Sales by Application (2017-2022) & (K Doses)

Table 61. Europe Pet Vaccine Sales Market Share by Application (2017-2022)

Table 62. Middle East & Africa Pet Vaccine Sales by Country (2017-2022) & (K Doses)

Table 63. Middle East & Africa Pet Vaccine Sales Market Share by Country (2017-2022)

Table 64. Middle East & Africa Pet Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 65. Middle East & Africa Pet Vaccine Revenue Market Share by Country (2017-2022)

Table 66. Middle East & Africa Pet Vaccine Sales by Type (2017-2022) & (K Doses)

Table 67. Middle East & Africa Pet Vaccine Sales Market Share by Type (2017-2022)

Table 68. Middle East & Africa Pet Vaccine Sales by Application (2017-2022) & (K Doses)

Table 69. Middle East & Africa Pet Vaccine Sales Market Share by Application (2017-2022)

Table 70. Key Market Drivers & Growth Opportunities of Pet Vaccine

Table 71. Key Market Challenges & Risks of Pet Vaccine

Table 72. Key Industry Trends of Pet Vaccine

Table 73. Pet Vaccine Raw Material

Table 74. Key Suppliers of Raw Materials

Table 75. Pet Vaccine Distributors List

Table 76. Pet Vaccine Customer List

Table 77. Global Pet Vaccine Sales Forecast by Region (2023-2028) & (K Doses)

Table 78. Global Pet Vaccine Sales Market Forecast by Region

Table 79. Global Pet Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Global Pet Vaccine Revenue Market Share Forecast by Region (2023-2028)

Table 81. Americas Pet Vaccine Sales Forecast by Country (2023-2028) & (K Doses)

Table 82. Americas Pet Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. APAC Pet Vaccine Sales Forecast by Region (2023-2028) & (K Doses)

Table 84. APAC Pet Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 85. Europe Pet Vaccine Sales Forecast by Country (2023-2028) & (K Doses)

Table 86. Europe Pet Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Middle East & Africa Pet Vaccine Sales Forecast by Country (2023-2028) & (K Doses)

Table 88. Middle East & Africa Pet Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 89. Global Pet Vaccine Sales Forecast by Type (2023-2028) & (K Doses)

Table 90. Global Pet Vaccine Sales Market Share Forecast by Type (2023-2028)

Table 91. Global Pet Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 92. Global Pet Vaccine Revenue Market Share Forecast by Type (2023-2028)

Table 93. Global Pet Vaccine Sales Forecast by Application (2023-2028) & (K Doses)

Table 94. Global Pet Vaccine Sales Market Share Forecast by Application (2023-2028)

Table 95. Global Pet Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 96. Global Pet Vaccine Revenue Market Share Forecast by Application (2023-2028)

Table 97. Bayer Healthcare Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 98. Bayer Healthcare Pet Vaccine Product Offered

Table 99. Bayer Healthcare Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 100. Bayer Healthcare Main Business

Table 101. Bayer Healthcare Latest Developments

Table 102. Vetoquinol S.A Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 103. Vetoquinol S.A Pet Vaccine Product Offered

Table 104. Vetoquinol S.A Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 105. Vetoquinol S.A Main Business

Table 106. Vetoquinol S.A Latest Developments

Table 107. Boehringer Ingelheim Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 108. Boehringer Ingelheim Pet Vaccine Product Offered

Table 109. Boehringer Ingelheim Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 110. Boehringer Ingelheim Main Business

Table 111. Boehringer Ingelheim Latest Developments

Table 112. Ceva Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 113. Ceva Pet Vaccine Product Offered

Table 114. Ceva Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 115. Ceva Main Business

Table 116. Ceva Latest Developments

Table 117. Eli Lilly Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 118. Eli Lilly Pet Vaccine Product Offered

Table 119. Eli Lilly Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 120. Eli Lilly Main Business

Table 121. Eli Lilly Latest Developments

Table 122. Heska Co. Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 123. Heska Co. Pet Vaccine Product Offered

Table 124. Heska Co. Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 125. Heska Co. Main Business

Table 126. Heska Co. Latest Developments

Table 127. Merck Animal Health Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 128. Merck Animal Health Pet Vaccine Product Offered

Table 129. Merck Animal Health Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 130. Merck Animal Health Main Business

Table 131. Merck Animal Health Latest Developments

Table 132. Merial (Sanofi) Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 133. Merial (Sanofi) Pet Vaccine Product Offered

Table 134. Merial (Sanofi) Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 135. Merial (Sanofi) Main Business

Table 136. Merial (Sanofi) Latest Developments

Table 137. Virbac Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 138. Virbac Pet Vaccine Product Offered

Table 139. Virbac Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 140. Virbac Main Business

Table 141. Virbac Latest Developments

Table 142. Zoetis (Pfizer) Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 143. Zoetis (Pfizer) Pet Vaccine Product Offered

Table 144. Zoetis (Pfizer) Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 145. Zoetis (Pfizer) Main Business

Table 146. Zoetis (Pfizer) Latest Developments

List of Figures

Figure 1. Picture of Pet Vaccine

Figure 2. Pet Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Pet Vaccine Sales Growth Rate 2017-2028 (K Doses)

Figure 7. Global Pet Vaccine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Pet Vaccine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Attenuated Live Vaccines

Figure 10. Product Picture of Conjugate Vaccines

Figure 11. Product Picture of Inactivated Vaccines

Figure 12. Product Picture of Subunit Vaccines

Figure 13. Product Picture of Toxoid Vaccines

Figure 14. Product Picture of DNA Vaccines

Figure 15. Product Picture of Recombinant Vaccines

Figure 16. Global Pet Vaccine Sales Market Share by Type in 2021

Figure 17. Global Pet Vaccine Revenue Market Share by Type (2017-2022)

Figure 18. Pet Vaccine Consumed in Canine

Figure 19. Global Pet Vaccine Market: Canine (2017-2022) & (K Doses)

Figure 20. Pet Vaccine Consumed in Avian

Figure 21. Global Pet Vaccine Market: Avian (2017-2022) & (K Doses)

Figure 22. Pet Vaccine Consumed in Feline

Figure 23. Global Pet Vaccine Market: Feline (2017-2022) & (K Doses)

Figure 24. Global Pet Vaccine Sales Market Share by Application (2017-2022)

Figure 25. Global Pet Vaccine Revenue Market Share by Application in 2021

Figure 26. Pet Vaccine Revenue Market by Company in 2021 ($ Million)

Figure 27. Global Pet Vaccine Revenue Market Share by Company in 2021

Figure 28. Global Pet Vaccine Sales Market Share by Geographic Region (2017-2022)

Figure 29. Global Pet Vaccine Revenue Market Share by Geographic Region in 2021

Figure 30. Global Pet Vaccine Sales Market Share by Region (2017-2022)

Figure 31. Global Pet Vaccine Revenue Market Share by Country/Region in 2021

Figure 32. Americas Pet Vaccine Sales 2017-2022 (K Doses)

Figure 33. Americas Pet Vaccine Revenue 2017-2022 ($ Millions)

Figure 34. APAC Pet Vaccine Sales 2017-2022 (K Doses)

Figure 35. APAC Pet Vaccine Revenue 2017-2022 ($ Millions)

Figure 36. Europe Pet Vaccine Sales 2017-2022 (K Doses)

Figure 37. Europe Pet Vaccine Revenue 2017-2022 ($ Millions)

Figure 38. Middle East & Africa Pet Vaccine Sales 2017-2022 (K Doses)

Figure 39. Middle East & Africa Pet Vaccine Revenue 2017-2022 ($ Millions)

Figure 40. Americas Pet Vaccine Sales Market Share by Country in 2021

Figure 41. Americas Pet Vaccine Revenue Market Share by Country in 2021

Figure 42. United States Pet Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 43. Canada Pet Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 44. Mexico Pet Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 45. Brazil Pet Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 46. APAC Pet Vaccine Sales Market Share by Region in 2021

Figure 47. APAC Pet Vaccine Revenue Market Share by Regions in 2021

Figure 48. China Pet Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 49. Japan Pet Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 50. South Korea Pet Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 51. Southeast Asia Pet Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 52. India Pet Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 53. Australia Pet Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 54. Europe Pet Vaccine Sales Market Share by Country in 2021

Figure 55. Europe Pet Vaccine Revenue Market Share by Country in 2021

Figure 56. Germany Pet Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 57. France Pet Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 58. UK Pet Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 59. Italy Pet Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 60. Russia Pet Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 61. Middle East & Africa Pet Vaccine Sales Market Share by Country in 2021

Figure 62. Middle East & Africa Pet Vaccine Revenue Market Share by Country in 2021

Figure 63. Egypt Pet Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 64. South Africa Pet Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 65. Israel Pet Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 66. Turkey Pet Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 67. GCC Country Pet Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 68. Manufacturing Cost Structure Analysis of Pet Vaccine in 2021

Figure 69. Manufacturing Process Analysis of Pet Vaccine

Figure 70. Industry Chain Structure of Pet Vaccine

Figure 71. Channels of Distribution

Figure 72. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390